Roche Holding : Illumina Dealogic Deal # : 789370
Data as of : 3/28/2012
Target Acquiror Dates & Values
Illumina Roche Holding
Target: 100 % stake Buying: 100 % stake Rumored - Deal Value $m 5,991.3
NS ILMN 122 m shares outstanding Public (Listed) Announced 25th Jan 2012 Value ex Debt $m 5,991.3
United States Switzerland
Healthcare Healthcare Expected 2Q 2012 Consideration
Goldman Sachs | Advisor Greenhill | Advisor Completed -
BAML | Advisor Citi | Advisor
Dewey & LeBoeuf | Attorney Davis Polk & Wardwell | Attorney Withdrawn -
Gibson Dunn & Crutcher | Advisor Attorney
Shearman & Sterling | Advisor Attorney Termination Fee, Target $m tbd
Termination Fee, Acquiror $m tbd
Financials 1st Jan 2012
Balance Sheet Debt/Equity: 1
Timeline Events Premiums & Multiples
Initial Offer $45
Current Offer $45
Income Statement
Cash Flows
Operations $m 358
Profitability
Profit Margin 22%
Return on Equity 8%
League Table Impact Sector Trend
2012 YTD Announced Global M&A by Deal Value, $bn Monthly Announced Global M&A, $bn: Healthcare
1 JPMorgan 129.0
2 Citi 115.0
3 Goldman Sachs 110.5
4 Morgan Stanley 108.5
5 Deutsche Bank 106.2
6 Barclays 94.2
7 Credit Suisse 89.4
8 Nomura 61.1
9 BAML 59.4
10 BNP Paribas 52.7
28 Greenhill & Co 7.3
2012 Dealogic. All rights reserved.